This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Europe's premier partnering event
November 4–6, 2024 | Stockholm, SwedenNovember 12–13, 2024 | Digital Partnering

Tiziana Life Sciences


Tiziana Life Sciences is a Nasdaq listed company with a goal to help sufferers of neuroinflammatory diseases. These include Non-active, secondary progressive multiple sclerosis, Alzheimer's this includes being used alongside recent approvals where neuroinflammation is still present, ALS, Long Covid, T1D. We also have promising pre clinical studies in ICH and TBI. We have an ongoing expanded access program where we have human data in SPMS before we opened our phase 2 trial in this indication. PET imaging from this EA program shows considerable reduction in microglia activity.